DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma

Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway

(2019) Wen-Chien Huang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Slc6a8-Mediated Creatine Uptake and Accumulation Reprogram Macrophage Polarization via Regulating Cytokine Responses

(2019) Liangliang Ji et al.   IMMUNITY

Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance

(2019) Monish Ram Makena et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

(2019) Kathryn C. Arbour et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC

(2019) Lai Wei et al.   Nature Communications

Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance

(2019) Teeuwssen et al.   Journal of Clinical Medicine

HMGB1-containing nucleosome mediates chemotherapy-induced metastasis of human lung cancer

(2018) Kailing Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cancer incidence and mortality in China, 2014

(2018) Wanqing Chen et al.   Chinese Journal of Cancer Research

Chemotherapy-induced metastasis: mechanisms and translational opportunities

(2018) George S. Karagiannis et al.   CLINICAL & EXPERIMENTAL METASTASIS

PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer

(2018) Zhiwang Song et al.   GENE

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Progress in adjuvant systemic therapy for breast cancer

(2018) Noam F. Pondé et al.   Nature Reviews Clinical Oncology

Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models

(2018) Ioanna Keklikoglou et al.   NATURE CELL BIOLOGY

Lung cancer: current therapies and new targeted treatments

(2017) Fred R Hirsch et al.   LANCET

Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism

(2017) George S. Karagiannis et al.   Science Translational Medicine

First-Line Systemic Therapy Practice Patterns and Concordance With NCCN Guidelines for Patients Diagnosed With Metastatic NSCLC Treated at NCCN Institutions

(2017) Carrie Zornosa et al.   Journal of the National Comprehensive Cancer Network

Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles

(2016) Antonio Rossi et al.   Expert Review of Anticancer Therapy

Wnt signaling in cancer

(2016) T Zhan et al.   ONCOGENE

Host effects contributing to cancer therapy resistance

(2015) Ofrat Beyar Katz et al.   DRUG RESISTANCE UPDATES

Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients

(2015) Rodrigo Dienstmann et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

(2015) W. Onstenk et al.   MOLECULAR CANCER THERAPEUTICS

Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature

(2014) I Fukumoto et al.   BRITISH JOURNAL OF CANCER

EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis

(2014) Haizhong Feng et al.   JOURNAL OF CLINICAL INVESTIGATION

Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis

(2013) Lei Nie et al.   JOURNAL OF CLINICAL INVESTIGATION

Maintenance Chemotherapy for Advanced Non–Small-Cell Lung Cancer: New Life for an Old Idea

(2013) David E. Gerber et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies

(2013) L G M Daenen et al.   ONCOGENE

Ensemble of Gene Signatures Identifies Novel Biomarkers in Colorectal Cancer Activated through PPARγ and TNFα Signaling

(2013) Stefano Maria Pagnotta et al.   PLoS One

MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells

(2012) Jean-Philippe Guégan et al.   CARCINOGENESIS

Expression of AP-2α, AP-2γ and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value

(2012) Simona Osella-Abate et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Potential Association of DCBLD2 Polymorphisms with Fall Rates of FEV1 by Aspirin Provocation in Korean Asthmatics

(2012) Tae-Joon Park et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

DCBLD2 Gene Variations Correlate with Nasal Polyposis in Korean Asthma Patients

(2012) Charisse Flerida A. Pasaje et al.   LUNG

Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids

(2011) Jeanine M.L. Roodhart et al.   CANCER CELL

A Wnt Survival Guide: From Flies to Human Disease

(2009) Andy J. Chien et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Identification of novel neuroendocrine-specific tumour genes

(2008) E Hofsli et al.   BRITISH JOURNAL OF CANCER

Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial

(2008) J.-Y. Pierga et al.   CLINICAL CANCER RESEARCH

Epigenetic Down-Regulation and Suppressive Role of DCBLD2 in Gastric Cancer Cell Proliferation and Invasion

(2008) M. Kim et al.   MOLECULAR CANCER RESEARCH